Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30174
Implementation of a “DIVA“ Concept withspecific Elisa Kits; When Subunit H5 Avian Influenza Vaccine is used

Authors: Robles F, Uribe A, Guadarrama A , Castellanos L, González C.

Abstract:

The main objective of this study was to demonstrate that differentiation of infected and vaccinated animals (DIVA) strategy using different ELISA tests is possible when a subunit vaccine (Haemagglutinin protein) is used to prevent Avian influenza. Special emphasis was placed on the differentiation in the serological response to different components of the AIV (Nucleoprotein, Neuraminidase, Haemagglutinin, Nucleocapsid) between chickens that were vaccinated with a whole virus kill vaccine and recombinant vaccine. Furthermore, the potential use of this DIVA strategy using ELISA assays to detect Neuraminidase 1 (N1) was analyzed as strategy in countries where the field virus is H5N1 and the vaccine used is formulated with H5N2. Detection of AIV-s antibodies to any component in serum was negative for all animals on the study days 0-13. At study day 14 the titers of antibodies against Nucleoprotein (NP) and Nucleocapsid (NC) rose in the experimental groups vaccinated with Volvac® AI KV and were negatives during all the trial in the experimental groups vaccinated with a subunit H5; significant statistically differences were observed between these groups (p < 0.05). The seroconversion either Haemagglutinin or Neuraminidase was evident after 21 days post-vaccination in the experimental groups vaccinated with the respective viral fraction. Regarding the main aim of this study and according with the results that were obtained, use a combination of different ELISA test as a DIVA strategy is feasible when the vaccination is carry out with a subunit H5 vaccine. Also is possible to use the ELISA kit to detect Neuraminidase (either N1 or N2) as a DIVA concept in countries where H5N1 is present and the vaccination programs are done with H5N2 vaccine.

Keywords: Avian Influenza Virus, "DIVA concept", ELISAassay, subunit H5 vaccine.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1062436

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1846

References:


[1] I. Capua, C. Terregino, G. Cattoli, F. Mistinelli and J. Rodríguez. "Development of a DIVA (Differentiating infected from vacinated animals) strategy using a vaccine containing a heterolologous neuroaminadase to control of avian influenza". Avian Patho. 32, pp. 47- 55. 2002.
[2] T. Ellis, L. Sims, H. Wong, C. Wong, K. Dyrting, K. Chow, C. Leung and J. Peiris. "Use of Avian Influenza Vaccination in Hong Kong". Dev Biol, 124, pp. 133-143. 2006.
[3] C. Lee and D. Suarez. "Avian influenza virus: prospects for prevention and control by vaccination". Animal Health Research Review. 6, pp. 1- 15. 2005.
[4] "Vaccination: a tool for the control of avian influenza" in OIE/FAO/IZSVe Scientific Conference, co-organised and supported by European Union, Verona (Italy), 20-22 March 2007.